BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
1134 results:

  • 1. Update on FDG-PET in pediatric lymphoma.
    Kurch L; Kluge R
    Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):58-69. PubMed ID: 38587361
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma.
    Shendy K; Abdelkawy K; Ali AA; Belal F; Abdelhakiem M; Magdy G; Anber N; Elbarbry F
    Xenobiotica; 2024 Feb; 54(2):95-105. PubMed ID: 38381003
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia.
    Kim J; Byun JM; Hong J; Koh Y; Shin DY; Kim TM; Yoon SS; Park H; Kim I
    Medicine (Baltimore); 2024 Feb; 103(7):e37100. PubMed ID: 38363899
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
    Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
    Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
    Ghezavati A; Liang CA; Mais D; Nazarullah A
    J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).
    Aljabry MS
    J Hematop; 2023 Mar; 16(1):27-31. PubMed ID: 38175368
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Optimal dosage of rituximab for children with Burkitt lymphoma.
    Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
    Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Broadening the horizon: potential applications of CAR-T cells beyond current indications.
    Karsten H; Matrisch L; Cichutek S; Fiedler W; Alsdorf W; Block A
    Front Immunol; 2023; 14():1285406. PubMed ID: 38090582
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Novel CD19-KIRS2/Dap12-BB CAR-T Treatment for 3 Patients with Relapsed and Refractory B-Cell Tumors].
    Ji SW; Hua T; Wang JJ; Shao LY; Chen ZH; Liu JY; Cheng H; Chen W; Sun C; Wang X; Xu KL; Cao J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1860-1865. PubMed ID: 38071073
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
    Ge T; Liu H; Wang ZH; Cao Y; Zhang YC; Huang L; Qian WB; Zhou XX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):825-831. PubMed ID: 38049334
    [No Abstract]    [Full Text] [Related]  

  • 12. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
    Gartenberg A; Winkel M; Leonard N
    Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Health Care Resource Utilization and Total Costs of Care for adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
    Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
    Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of Social Disparities on 5-Year Survival Rates in Pediatric Hematologic Malignancies.
    Chalfant V; Riveros C; Bechtel A; Bradfield SM; Stec AA
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):33-38. PubMed ID: 37910818
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
    Faria C; Gava F; Gravelle P; Valero JG; Dobaño-López C; Van Acker N; Quelen C; Jalowicki G; Morin R; Rossi C; Lagarde JM; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899130
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe.
    Din RU; Jiao A; Qiu Y; Mohan AAM; Yuen KC; Wong HT; Wan TM; Wong PO; Sin CF
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834095
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Metabolic/endocrine disorders in survivors of childhood-onset and cranial radiotherapy- treated ALL/NHL: a meta-analysis.
    Zhang D; Gu M
    Reprod Biol Endocrinol; 2023 Oct; 21(1):91. PubMed ID: 37794442
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
    Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
    Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015).
    Kuan JW; Su AT; Wahab M; Hamdan A; Hashim J; Kiyu A; Ooi CH
    BMC Cancer; 2023 Jun; 23(1):563. PubMed ID: 37337159
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Testicular dysfunction at diagnosis in children and teenagers with haematopoietic malignancies improves after initial chemotherapy.
    Lopez Dacal J; Prada S; Correa Brito L; Ropelato MG; Ballerini MG; Rodriguez ME; Gutiérrez ME; Soria M; Morán L; Ferraro C; Bedecarrás P; Drelichman G; Aversa L; Bergadá I; Rey RA; Grinspon RP
    Front Endocrinol (Lausanne); 2023; 14():1135467. PubMed ID: 37260445
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 57.